EPIX Pharmaceuticals Announces Resignation of Andrew Uprich

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » RSS Yahoo BIOTECH
Reply to topic
EPIX Pharmaceuticals Announces Resignation of Andrew Uprich
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Wed May 28, 2008 9:58 pm Reply with quote


LEXINGTON, Mass.----EPIX Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that Andrew Uprichard, M.D., president and head of research and development has resigned his position with EPIX effective May 21, 2008.

Read more...
View user's profileSend private message
EPIX Pharmaceuticals Announces Resignation of Andrew Uprich
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » RSS Yahoo BIOTECH
 Reply to topic  
Forum Map
Site Map